Interactions Between Natural Killer Cells, Cortisol and Prolactin in Malaria During Pregnancy

Abstract

Interactions Between Natural Killer Cells, Cortisol and Prolactin in Malaria During Pregnancy

Elie Mavoungou, PhD

Elie Mavoungou, PhD, Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon and Institute for Tropical Medicine, Department of Parasitology, University of Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany
 

Natural killer cells derived from pluripotent hematopoietic stem cells are important cells of the immune system that have two main functions: a cytolytic activity and a cytokine-producing capacity. These functions are tightly regulated by numerous activating and inhibitory receptors, including newly discovered receptors that selectively trigger the cytolytic activity in a major histocompatibility complex independent manner. Based on their defining function of spontaneous cytotoxicity without prior immunization, natural killer (NK) cells have been thought to play a critical role in immune surveillance and cancer therapy. New insights into NK cell biology have suggested their major roles in the control of infections, particularly in Plasmodium falciparum infection and in fetal implantation. P. falciparum is the main protozoan parasite responsible for malaria causing 200–300 million clinical cases and killing over 3 million people each year. This review provides an update on NK cell function, ontogeny and biology in order to better understand the role of NK cells in pregnancy in regions where malaria is endemic. Understanding mechanisms of NK cell functions may lead to novel therapeutic strategies for the treatment of human disease, in general, and particularly in the fight against malaria.

Keywords: Natural killer cells, Plasmodium falciparum, malaria, pregnancy

Source: Clin Med Res. vol 4(1) pp. 33–41,  March 2006

(Introduction)

(Introduction)

In areas of intense Plasmodium falciparum transmission, pregnancies are associated with substantial malaria-related morbidity and mortality. The mechanisms of protection against malaria are not fully understood. Protective immunity is acquired during childhood. Until recently, it has been poorly understood why the clinical protection against malaria is rendered inefficient when young women become pregnant. Over the last century, the epidemiology of pregnancy associated P. falciparum malaria has been the subject of numerous research articles with excellent reviews of this literature published.14 However, most of these reviews focus on the mounting evidence that protective immunity to pregnancy-associated malaria depend on acquisition of antibodies directed against parasite-encoded variant antigens on the surface of the infected red blood cells and only one gives attention on the “cortisol hypothesis.”2 This review will illustrate the cortisol hypothesis, and because natural killer (NK) cells play a crucial role in this hypothesis, an update on NK cell function and biology is provided in order to better understand the role of NK cells in the susceptibility of pregnant women to malaria.


Characterization of NK Cells

NK cells are large granular lymphocytes that comprise approximately 5% to 15% of peripheral blood mononuclear cells (PBMC) and 5% to 10% of lymph nodes. NK cells were first identified by their ability to lyse tumor cells without prior immunization. Actually, NK cells are defined as lymphocytes lacking the T cell receptor (TCR) complex and are CD3 negative. The best surface antigen to identify human NK cells is the neural cell adhesion molecule (CD56) first identified in brain tissue.5 Although CD56 may have adhesion function in neural tissue based on homotypic interactions,6 its function in NK cells remains unknown. Monoclonal antibodies to several other antigens can be used to identify important subsets of NK cells. CD16 (FcγRIII) is the Fc receptor expressed on the surface of CD56+dim NK cells that identifies the most mature cell population belonging to this lineage. Well-characterized unique NK cell subsets circulating in peripheral blood are CD56+bright NK cells7 that are minimally cytotoxic8 and highly proliferative.8,9 CD56+bright NK cells constitutively express interleukin (IL)-2 receptor and lack FcγRIII.10 They also express c-kit11 and the receptor for T cell factor-1 (TCF-1).12 The CD56+dim NK cells can be divided into subpopulations based upon CD2 expression. CD2 is the ligand for lymphocyte function-associated antigen-3 (LFA-3, or CD58). All NK cells express the lymphocyte marker CD7.13 CD8, also present on the cytotoxic population of T-cells, is expressed by approximately 35% of CD56+dim NK cells.9 In contrast to CD8+ T cells, where CD8 is composed of both α and β chains, CD8 expressed on the surface of NK cells is composed of predominantly CD8-α chains.14


Identification of Target Cells of NK Cells

Before their phenotypic characterization, NK cells were functionally defined as cells freshly isolated from blood with the ability to lyse tumor cell targets. Activation of NK cells with IL-2 induces cytolytic machinery and the capacity to lyse a broad range of tumor targets not lysed by resting NK cells. Although there has been much progress in understanding the signaling machinery of NK cells, the recognition events may be more complex. It is well known that β 2 integrins expressed on the surface of NK cells recognize intracellular adhesion molecule-1 (ICAM-1) on target cells.15,16 However, this may be one of several receptor ligand pairs that are involved in the recognition process. Another adhesion ligand pair, CD2 on NK cells, recognizes LFA-3 on target cells.17 Antibodies against β 2 integrins and CD2 variability interrupt cytotoxicity in a target-specific manner.18 Activating and inhibitory NK cell receptors (table 1) have now been shown to recognize a wide range of self and non-self antigens.


Regulation of NK Cell Function by Major Histocompatibility Complex (MHC) Class I Restricted Receptors

Regulation of NK Cell Function by Major Histocompatibility Complex (MHC) Class I Restricted Receptors

In contrast to T cells, NK cells kill a broad array of targets in a human leukocyte antigen (HLA)-unrestricted manner. However, recent observations counter the notion that NK killing is totally MHC-unrestricted. While antigen recognition presented by MHC class I molecules activates T cells, class I antigen presentation can render targets resistant to lysis by NK cells. Thus, NK cell receptor function may be activating and/or inhibitory (figure 1). As originally proposed by Ljunggren and Kärre19 in the “missing self ” hypothesis, it is now well recognized that class I downregulation by transformation or infection may make cells susceptible to NK cell lysis.20,21 Class I-recognizing NK receptors were identified first in the mouse as the Ly49 proteins, which are type II lectins capable of binding sugar moieties on class I molecules.22 Although a truncated nonfunctional Ly49L has been found in man, humans do not use Ly49 receptors.23 In contrast, human class I-recognizing NK cell receptors are type I membrane glycoproteins and members of the immunoglobulin superfamily that are not present in mice.24,25 Although thought initially to represent a paradox, it is now known that human NK cells express both immunoglobulin and lectin-type receptors.2628

Chromosome 19 is a hot spot for NK cell receptors defined by immunoglobulin structural moieties. Hence, they are termed killer immunoglobulin-like receptors (KIR). The individual receptor names are assigned by the number of corresponding immunoglobulin domains (e.g., KIR2D, KIR3D) and by the length of their associated cytoplasmic tail, either long (L) or short (S) (e.g., KIR2DL, KIR2DS1).2931 A KIR can signal inhibition or activation when class I MHC is recognized based on the length of its cytoplasmic tail. Long cytoplasmic tails contain immunoreceptor tyrosine-based inhibitory motifs that signal inhibition when the KIR is appropriately ligated. At least three of these inhibitory receptors (KIR2DL1, KIR2DL2, KIR3DL1) have class I ligands identified (cw4, cw3, bw4). KIR with short cytoplasmic tails non-covalently associates with cytoplasmic DAP12 molecules that signal activation when the KIR is ligated. DAP12 is a disulfide-bonded homodimer containing an immunoreceptor tyrosine-based activation motif and its gene is also found on chromosome 19.32,33 The function of inhibitory KIR is summarized in figure 2.


The Role of NK Cells During Infection

There are two mechanisms by which NK cells may affect disease. As already discussed above, NK cells do not kill targets that express “self ” class I HLA molecules. Viral infection, like some cancers, may downregulate class I MHC, allowing for killing of virally infected cells by direct cytotoxic mechanisms. A second major role of NK cells is their production of cytokines, which may be critically important to eliminate infections. Understanding of the pathophysiology of viral infection and immune recognition by NK cells has been advanced by the discovery of NK cell-inhibitory receptors that recognize MHC molecules. For instance, NK cell clones were isolated from peripheral blood to study the lysis of HeLa cells before and after infection with herpes simplex virus or cytomegalovirus (CMV). Both viral infected targets downregulate MHC class I molecules, making them undetectable by T cells, but more susceptible to NK cell killing than uninfected control cells.34 However, the factors that influence MHC class I expression are complex and may underlie the mechanisms of escape from NK cell-mediated lysis of virus-infected targets.

Several studies have evaluated the mechanisms of CMV infection and specificity of MHC downregulation. Unlike many viral proteins that downregulate class I molecules, CMV US2 and CMV US11 are specific to HLA-A and -B alleles, but do not affect HLA-C molecules showing allelic specificity.35 CMV UL40 has been interesting because of the homology between the signal sequence (amino acids 3–11) of most HLA-C alleles and the UL40 peptide (amino acids 15–23). Two independent laboratories have recently found UL40 sequence homology to HLA-E binding peptides.36,37 The first study used fibroblasts that constitutively express low levels of HLA-E to test UL40 constructs. UL40 bound HLA-E and increased its expression, without affecting expression of HLA-C, and protected against NK cell attack through CD94 lectin inhibitory receptors.36 The second study co-transfected HLA-E and UL40 into K562 cells, which became resistant to killing by NKG2A+ NK cell clones.37 Blocking antibodies to CD94 or HLA-E restored lysis, showing the specificity of this interaction. Therefore, some CMV proteins (US2 and US11) promote NK cell attack by downregulation of MHC, but UL40 has an opposing effect by stabilizing and upregulating HLA-E. Other viral proteins may have similar allelic specificity, but not all downregulation of MHC is necessarily associated with increased susceptibility to NK killing. Kaposi’s sarcoma-associated herpes virus (KSHV) proteins K3 and K5 dramatically downregulate class I molecules. K3 downregulates HLA-A, -B, -C and -E, while K5 downregulates HLA-A and -B. Surprisingly, KSHV K5 transduced targets, which do not downregulate Cw4, were resistant to an NK cell line that lacked a Cw4-specific KIR.38 Thus, K3 induces target sensitivity by MHC downregulation, and K5 induces resistance independent of MHC expression. The mechanism of this K5-induced resistance was found to be by downregulation of target cell intracellular adhesion molecule-1 needed for NK recognition and downregulation of B7-2 needed for effector cell activation. This illustrates a novel mechanism by which KSHV downregulates class I molecules, which should make it more susceptible to NK lysis but, by other mechanisms, escapes this immune control.

Interferon (IFN)-γ is probably the most important cytokine produced by NK cells with anti-infection activity. Mice that lack IFN-γ receptors have an increased susceptibility to murine CMV, listeria monocytogenes and the protozoan parasite, Toxoplasma gondii.39 Detailed studies of murine CMV infection show that IFN-γ and tumor necrosis factor (TNF)- α levels are upregulated in mice infected with murine CMV.40 By selective depletion of NK cells, IFN-γ production is eliminated, suggesting that NK cells are the primary producers of this cytokine. The role of IFN-γ in the pathogenesis of murine CMV is suggested by studies using monoclonal antibodies to neutralize IFN-γ, resulting in an increase in viral replication and subsequent severity of viral hepatitis. Interestingly, neutralizing IFN-γ does not alter direct cytotoxicity, suggesting that direct killing of infected cells is not the mechanism of NK cell control of murine CMV. Further studies showed that IL-12 stimulates IFN-γ in NK cells to mediate a protective effect against murine CMV. This may be virus-specific since lymphocyte choriomeningitis virus does not induce IFN-γ and was not affected by IL-12 neutralization.41


NK Cells and Malaria

In P. falciparum infection, disease occurs only as a result of the asexual blood stage after the parasite leaves the liver and begins to invade and grow inside red blood cells. Important insight into the role of NK cells in immunity to malaria was provided on IL-12-related mechanisms in early stages of the disease in the model.42 Indeed, infection of mice can be ameliorated by administration of IL-12 early in the course of the infection. Untreated mice died 12 days after infection, while IL-12 treated mice survived. Administration of IL-12 early in the course of the disease improves the outcome of the infection in normal mice, leading to the development of IFN-γ, TNF-α and nitric oxide-dependent immunity.43 The role of nitric oxide was investigated by the administration of aminoguanidine, a selective inhibitor of cytokine inducible nitric oxide synthetase. Significantly increased mortality was observed following treatment twice daily with 9 mg of aminoguanidine, but there was no effect on parasitemia. Furthermore, in vivo depletion of NK cells after anti-GM1 antibody treatment results in a severely increased pathology, and IL-12-treated but NK cell-depleted A/J mice fully fail to control the infection.44 More recently, the role of NK cells in control of human malaria has begun to be investigated. Artavanis-Tsakonas and Riley46 have revealed that, in non-immune donors, NK cells are among the first cells in peripheral blood to produce IFN-γ in response to P. falciparum-infected red blood cells. In this setting, the authors observed that NK cells are activated during the first 18 hours of exposure to parasitized erythrocytes. This activation was dependent on IL-12 and also to a lesser extent on IL-18. Interestingly, cells from semi-immune African adults produce less IFN-γ, which might reflect haplotypic variation in KIR genotype among individuals and/or extensive functional allelic polymorphisms in KIR and toll like receptors.4648 These results were obtained with whole blood cells. Using purified cells, we have recently shown that NK cells from nonimmune individuals can kill plasmodia-infected erythrocytes in the absence of opsonizing antibodies directly through cell-cell interaction and that this activity was inhibited by anti-Fas antibody and granzyme B inhibitor.49 We also provide evidence that purified NK cells can inhibit growth of Plasmodia-infected erythrocytes opsonized with antibody from semi-immune African adults by around 25%, and that pre-treatment of NK cells with anti-Fas and granzyme B inhibitor prevents this growth inhibition.49


The Role of NK Cells in the Pregnant Uterus

Any discussion of the normal physiology of NK cells would be lacking without mention of their putative role in pregnancy. It has long been recognized that large granular lymphocytes of NK cell origin are the major lymphocyte populations lining the pregnant uterus.50 Uterine NK cells achieve peak numbers during the first trimester, when they represent 70% of all lymphocytes, and are not found at term.51 Uterine NK cells are different than mature circulating NK cells, yet phenotypically resemble the smaller unique blood NK cell subset, CD56+bright/CD16/CD3,52 and has low direct cytotoxicity. Since IL-2 is not produced in the placenta, proliferation of uterine NK cells is through production of IL-15 by placental macrophages and the IL-15 receptor on CD56+bright uterine NK cells.53 Significant progress has been made in understanding the role of NK cells by evaluating mice that lack NK cells. These mice are able to bear offspring but with 64% fetal loss.54 In addition, they have no endometrial glands, decreased placental size, decidual edema and abnormalities involving the large maternal arterioles supplying the placenta.50,55 The causal relationship between this phenotype and the role of NK cells was established by showing that T cell-deficient mice do not exhibit these abnormalities and transplantation of stem cells from severe combined immune deficient mice (which have normal NK cells but no T cells) into the NK cell-deficient mice reverses the phenotype.56 These studies show that CD56+bright NK cells occupying the mesometrial side of the pregnant uterus contribute to fetal implantation. Recent progress has been made in understanding this mechanism.

Since transgenic [var epsilon]26 mice have a 10-fold lower concentration of uterine IFN-γ,56 Ashkar and colleagues57 investigated mice lacking IFN-γ or IFN-γ receptor α-receptors. These latter two knockouts had an excessive number of uterine NK cells that were small and had limited numbers of cytoplasmic granules. The decidual arteries did not undergo normal gestation-induced remodeling. In contrast to the hypocellularity of the decidua in the NK cell knockout mice, decidua in the IFN-γ deficient mice progressed to overt necrosis during the second half of gestation. Further experiments used the RAG-2/common γ chain knockout mice, which also lack NK cells. As expected, these mice had very low concentrations of IFN-γ in the uterus. Engraftment of these NK-deficient mice with IFN-γ knockout marrow resulted in normal numbers of NK cells in the uterus, but an inability to initiate pregnancy-induced remodeling of spiral arteries.58 Interestingly, treatment with murine IFN-γ (100–1000 units per day x 6 days) reversed this defect and resulted in normal decidual artery remodeling. Taken together, these studies suggest that IFN-γ modulates the NK cell pool resident in the uterus, that uterine NK cell-derived IFN-γ is not necessary for initiation of decidualization, but appears essential for decidual maintenance in the second trimester.

It is intriguing that trophoblasts lack class I and class II HLA molecules but highly express nonclassical HLA-G, which is restricted to the placenta.59,60 Since NK cells have receptors for nonclassical class I molecules, some have hypothesized that HLA-G protects fetal cells from lysis by maternal NK cells through this mechanism. Using a migration assay, NK cell trafficking through the HLA-G-expressing endothelial cells was reduced.61 Recent studies show that HLA-G expression may interact with HLA-E molecules. Trophoblast cells were purified by flow cytometry and found to express HLA-E by reverse transcriptase polymerase chain reaction and immunoprecipitation.62 Staining with HLA-E tetrameric complexes refolded with the leader peptide derived from HLA-G identified 93% of decidual NK cells compared to 55% from the peripheral blood of non-pregnant women, suggesting the importance of NK cell lectin receptors in pregnancy. KIR may also be important, since uterine NK cells in the first trimester of pregnancy and essentially on all NK cells obtained from the placenta at term were found to express the p49 receptor, now termed KIR2DL4. KIR2DL4 was shown to directly bind HLA-G and may protect trophoblast cells from lysis by NK cells.60 Lanier62 has pointed out that it is still not clear whether KIR2DL4/HLA-G interactions are physiologic. These concerns are based on two possibly contradictory findings: 1) a woman found to have an HLA-Gnull mutation had normal fetal development and 2) fetal mice with β-2 microglobulin genes knocked out are not rejected by their heterozygous mother. Further studies into the role of NK cells in pregnancy will define these interactions and their physiologic relevance. Abnormal functions of NK cells in women with recurrent spontaneous abortions have been postulated. There seems to be a correlation with recurrent spontaneous abortion and increased NK cell cytotoxicity and an abnormally high decidual CD56+/CD16 ratio compared to normal pregnancies.63 A better understanding of NK cells in pregnancy may lead to important new therapies to prevent fetal loss.


Malaria During Pregnancy

Malaria is endemic in more than 100 countries. Over two billion people living in these endemic countries are exposed to P. falciparum infection. Children less than 6 years old and pregnant women are at increased risk of P. falciparum malaria and its associated complications. Approximately 50 million women become pregnant every year in malaria endemic regions.64 Pregnancy-associated malaria is estimated to be responsible for a third of preventable low birth weight babies in sub-Saharan Africa and to cost the lives of approximately 200,000 infants annually.65 Women are more susceptible to infection when pregnant, and both the frequency and the severity of the disease are higher in pregnant than non-pregnant women.1 In areas where malaria is highly endemic, a protective semi-immunity against P. falciparum is acquired during the first 10–15 years of life with the majority of malaria-related morbidity and mortality happening in young children.66 However, in contrast with low malaria prevalence in adults, pregnant women in endemic areas are highly susceptible to malaria.1

In pregnancy, there is a transient depression of cell-mediated immunity that allows fetal allograft retention but also interferes with resistance to various infectious diseases.67 Cellular immune responses to P. falciparum antigens are depressed in pregnant women in comparison with non-pregnant control women.65,68

Anti-adhesion antibodies against chondroitin sulfate A-binding parasite are associated with protection from maternal malaria, but these antibodies develop only over successive pregnancies, accounting for the susceptibility of primigravidae to infection.69 Indeed, women in first and second pregnancies are the most affected, with both gravidity and premunition influencing susceptibility to malarial infection.70


Cortisol, Prolactin and Susceptibility of Pregnant Women to Malaria

The immune system destroys infected cells and rebuilds tissue.71 Similar processes are driven by hormones. In women, during the 9 days preceding ovulation (the proliferative phase) the endometrium becomes built up, highly vascularized and infiltrated with small NK cells.72,73 Ovulation defines the beginning of the 14-day secretory phase during which NK cells proliferate and differentiate. In the secretory phase, an embryo can implant or die off, in the presence or absence of NK cells, respectively. Upon implantation of an embryo, the menstrual cycle is broken and pregnancy starts.

Whereas NK cells represent approximately 10% of cells in peripheral blood, uterine NK cells constitute 60% to 90% of the leukocytes in the decidua, a tissue in which B lymphocytes and T lymphocytes are rare. Two types of NK cells are distinguished, those expressing low levels of CD56 and specialized in cytolysis, and those expressing high levels of CD56 and involved in cytokine secretion.74 Uterine NK cells express the highest amount of CD56.75

Cortisol, an adrenocortical hormone in humans suppresses the immune system and directly inhibits NK cell activity.7678 Conversely, prolactin, a 24 kDa single chain hormone secreted by the anterior pituitary gland, is an immunostimulatory “cytokine”79,80 that directly affects NK cell function.81

NK cell cytolytic activity decreases significantly during pregnancy and NK cytotoxic activity defect has been reported in pregnant women.82,83 We measured NK cell cytotoxicity in peripheral venous blood samples obtained from pregnant Gabonese women at the time of delivery. The NK cell-mediated cytotoxicity against P. falciparum-infected erythrocytes in vitro was lower in samples obtained from primiparous women than in multiparous ones.84 However, these findings were discussed and contested by Pearson.85 He supported the “prolactin hypothesis” and pointed out that labor was not an appropriate time to assay for prolactin levels because they naturally fall 24 hours preceding the onset of delivery. Nevertheless, we and others have demonstrated that the surface expression and function of the triggering receptors responsible for NK-mediated recognition and killing of tumor cells is regulated by hormones.85,86 Prolactin selectively upregulates the surface expression of NKp46 and NKp30. In contrast, cortisol downregulates the expression of NKp30.86 Our data are interesting because NKp30 acts together with NKp46 to induce cytotoxic activity against a variety of target cells. These results have important implications for the understanding of the involvement of NK cells in the susceptibility of pregnant women to P. falciparum malaria. Pregnant women living in endemic areas are most susceptible to malaria between the second trimester and the early postpartum period.87

We recently reported that cortisol and prolactin concentrations increase during pregnancy, regardless of parity. We found that cortisol concentrations were higher in primigravidae than in multigravidae, and also higher in P. falciparum-infected primigravidae than in uninfected primigravidae throughout pregnancy and at the time of delivery.88 We showed that prolactin concentration did not differ according to P. falciparum status. The low NK cell cytotoxic activity we found was correlated with high cortisol concentrations. Some studies have found that exogenous cortisol suppresses NK cell cytotoxicity89 and that subphysiological concentration of cortisol results in direct functional inactivation.74,75 Moreover, the surface density of natural cytotoxicity receptors is directly correlated with the magnitude of NK cell cytolytic activity against several target cell types.90 We, therefore, hypothesize that the difference in NK cell cytotoxic activity against P. falciparum-infected erythrocytes observed between primiparous and multiparous women can be partially explained by the difference in cortisol concentrations found in these two groups of pregnant women.


Conclusion

NK cells are important cells of the immune system derived from stem cells in the marrow. Their function in infectious diseases and pregnancy is controlled through a complex system of cell receptors to control cell proliferation, cytotoxicity and cytokines. The production of hormones and other pregnancy regulatory factors in primigravidae may alter cell function, thereby conferring an advantage for malaria infection. A causal relationship between high cortisol levels and depressed NK cell cytotoxicity against P. falciparum-parasitized erythrocytes and susceptibility to malaria has been demonstrated. Parasitized erythrocytes become sensitive to NK cytolysis and prolactin, and cortisol serum levels were related with NK cells cytolytic activity. Despite limited success in currently reported therapeutic trials, understanding the biology of NK cells and their homing mechanisms in vivo may lead to novel therapeutic strategies. However, much research remains to be done.


References

1.
Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983;61:1005–1016.
2.
McGregor IA. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 1984;33:517–525.
3.
Brabin BJ, Rogerson SJ. The epidemiology and outcomes of maternal malaria. In: Duffy PE, Fried M, eds. Malaria in pregnancy: Deadly parasite, susceptible host. London: Taylor & Francis; 2001. 27–52.
4.
Okoko BJ, Enwere G, Ota MO. The epidemiology and consequences of maternal malaria: a review of immunological basis. Acta Trop 2003;87:193–205.
5.
Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989;169:2233–2238.
6.
Rutishauser U, Acheson A, Hall AK, Mann DM, Sunshine J. The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 1988;240:53–57.
7.
Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med 1990;171:1509–1526.
8.
Nagler A, Lanier LL, Cwirla S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989;143:3183–3191.
9.
Miller JS, Oelkers S, Verfaillie C, McGlave P. Role of monocytes in the expansion of human activated natural killer cells. Blood 1992;80:2221–2229.
10.
Nagler A, Lanier LL, Phillips JH. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. J Exp Med 1990;171:1527–1533.
11.
Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci U S A 1994;91:7553–7557.
12.
Toor AA, Lund TC, Miller JS. T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells. Exp Hematol 2001;29:499–506.
13.
Pierson BA, Miller JS. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Blood 1996;88:2279–2287.
14.
Baume DM, Caligiuri MA, Manley TJ, Daley JF, Ritz J. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell Immunol 1990;131:352–365.
15.
Klein E, Di Renzo L, Yefenof E. Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells. Mol Immunol 1990;27:1343–1347.
16.
Melero I, Balboa MA, Alonso JL, Yague E, Pivel JP, Sanchez-Madrid F, Lopez-Botet M. Signaling through the LFA-1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-alpha production in natural killer cells. Eur J Immunol 1993;23:1859–1865.
17.
Tangye SG, Phillips JH, Lanier LL. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin Immunol 2000;12:149–157.
18.
Miller JS. NK-cell target recognition and killing is activation-dependent and target-specific. In: Schlossman SF, Boumsell L, Gilks W, et al. (eds). Leukocyte typing V. Vol. 1. Oxford: Oxford University Press; 1995. 1431.
19.
Ljunggren HG, Karre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990;11:237–244.
20.
Raulet DH, Held W. Natural killer cell receptors: the offs and ons of NK cell recognition. Cell 1995;82:697–700.
21.
Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev 1997;155:145–154.
22.
Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992;358:66–70.
23.
Westgaard IH, Berg SF, Orstavik S, Fossum S, Dissen E. Identification of a human member of the Ly-49 multigene family. Eur J Immunol 1998;28:1839–1846.
24.
Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405–408.
25.
Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439–449.
26.
Yokoyama WM. What goes up must come down: the emerging spectrum of inhibitory receptors. J Exp Med 1997;186: 1803–1808.
27.
Steffens U, Vyas Y, Dupont B, Selvakumar A. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. Tissue Antigens 1998;51:398–413.
28.
Long EO, Burshtyn DN, Clark WP, Peruzzi M, Rajagopalan S, Rojo S, Wagtmann N, Winter CC. Killer cell inhibitory receptors: diversity, specificity, and function. Immunol Rev 1997;155:135–144.
29.
Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753–763.
30.
Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D’Andrea A, Phillips JH, Lanier LL, Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997;7:739–751
31.
Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L. The human leukocyte antigen (HLA)-C-specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183:645–650.
32.
Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998;391:703–707.
33.
Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998;8:693–701.
34.
Huard B, Fruh K. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur J Immunol 2000;30:509–515.
35.
Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med 1998;188:497–503.
36.
Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000;287:1031.
37.
Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, Pla M, Weiss EH. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol 2000;164:5019–5022.
38.
Ishido S, Choi JK, Lee BS, Wang C, DeMaria M, Johnson RP, Cohen GB, Jung JU. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi’s sarcoma-associated herpesvirus K5 protein. Immunity 2000;13:365–374.
39.
Taylor GA, Collazo CM, Yap GS, Nguyen K, Gregorio TA, Taylor LS, Eagleson B, Secrest L, Southon EA, Reid SW, Tessarollo L, Bray M, McVicar DW, Komschlies KL, Young HA, Biron CA, Sher A, Vande Woude GF. Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A 2000;97:751–755.
40.
Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995;182:1045–1056.
41.
Orange JS, Biron CA. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996;156:1138–1142.
42.
Kawakami K, Koguchi Y, Qureshi MH, Miyazato A, Yara S, Kinjo Y, Iwakura Y, Takeda K, Akira S, Kurimoto M, Saito A IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. J Immunol 2000;165:941–947.
43.
Stevenson MM, Su Z, Sam H, Mohan K. Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity. Microbes Infect 2001;3:49–59.
44.
Stevenson MM, Tam MF, Wolf SF, Sher A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J Immunol 1995;155:2545–2556.
45.
Mohan K, Moulin P, Stevenson MM. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol 1997;159:4990–4998.
46.
Artavanis-Tsakonas K, Riley EM. Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol 2002;169:2956–63.
47.
Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753–763.
48.
Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187–191.
49.
Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens 2001;57:22–31.
50.
Mavoungou E, Luty AJ, Kremsner PG. Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum-infected human red blood cells in vitro. Eur Cytokine Netw 2003;14:134–142.
51.
Ashkar AA, Croy BA. Interferon-gamma contributes to the normalcy of murine pregnancy. Biol Reprod 1999;61:493–502.
52.
Croy BA, Ashkar AA, Minhas K, Greenwood JD. Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia? J Soc Gynecol Investig 2000;7:12–20.
53.
Faust Z, Laskarin G, Rukavina D, Szekeres-Bartho J. Progesterone-induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol 1999;42:71–75.
54.
Verma S, Hiby SE, Loke YW, King A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 2000;62:959–968.
55.
Guimond M, Wang B, Croy BA. Immune competence involving the natural killer cell lineage promotes placental growth. Placenta 1999;20:441–450.
56.
Redline RW Role of uterine natural killer cells and interferon gamma in placental development. J Exp Med 2000;192:F1–F4.
57.
Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 1998;187:217–223.
58.
Ashkar AA, Di Santo JP, Croy BA. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000;192:259–270.
59.
Dorling A, Monk NJ, Lechler RI. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 2000;30:586–593.
60.
Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A 1999;96:5674–5679.
61.
King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000;30:1623–1631.
62.
Lanier LL. Natural killer cells fertile with receptors for HLA-G? Proc Natl Acad Sci U S A 1999;96:5343–5345.
63.
Yamamoto T, Takahashi Y, Kase N, Mori H. Decidual natural killer cells in recurrent spontaneous abortion with normal chromosomal content. Am J Reprod Immunol 1999;41:337–342.
64.
Hviid L. The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective. Parasite Immunol 2004;26:477–486.
65.
Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001;64:28–35.
66.
Riley EM, Schneider G, Sambou I, Greenwood BM. Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. Am J Trop Med Hyg 1989;40:141–144.
67.
Meeusen EN, Bischof RJ, Lee CS. Comparative T-cell responses during pregnancy in large animals and humans. Am J Reprod Immunol 2001;46:169–179.
68.
Fievet N, Cot M, Chougnet C, Maubert B, Bickii J, Dubois B, Le Hesran JY, Frobert Y, Migot F, Romain F, Verhave JP, Louis F, Deloron P. Malaria and pregnancy in Cameroonian primigravidae: Humoral and cellular immune responses to Plasmodium falciparum blood-stage antigens Am.J.Trop.Med.Hyg 1995;53 :612–617.
69.
Duffy PE, Fried M. Malaria during pregnancy: parasites, antibodies and chondroitin sulphate A. Biochem Soc Trans 1999;27:478–482.
70.
Bouvier P, Doumbo O, Breslow N, Robert CF, Mauris A, Picquet M, Kouriba B, Dembele HK, Delley V, Rougemont A. Seasonality, malaria, and impact of prophylaxis in a West African village I. Effect of anemia in pregnancy. Am J Trop Med Hyg 1997;56:378–383.
71.
Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301–305.
72.
Bulmer JN, Hollings D, Ritson A. Immunocytochemical evidence that endometrial stromal granulocytes are granulated lymphocytes. J Pathol 1987;153:281–288.
73.
King A, Birkby C, Loke YW. Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol 1989;118:337–344.
74.
Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001;97:3146–3151.
75.
King A, Balendran N, Wooding P, Carter NP, Loke YW. CD3- leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Dev Immunol 1991;1:169–190.
76.
Callewaert DM, Moudgil VK, Radcliff G, Waite R Hormone specific regulation of natural killer cells by cortisol. Direct inactivation of the cytotoxic function of cloned human NK cells without an effect on cellular proliferation. FEBS Lett 1991;285:108–110.
77.
Gatti G, Cavallo R, Sartori ML, del Ponte D, Masera R, Salvadori A, Carignola R, Angeli A. Inhibition by cortisol of human natural killer (NK) cell activity. J Steroid Biochem 1987;26:49–58.
78.
Zhou J, Olsen S, Moldovan J, Fu X, Sarkar FH, Moudgil VK, Callewaert DM. Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line. Cell Immunol 1997;178:108–116.
79.
Jara LJ, Lavalle C, Fraga A, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Germain BF, Espinoza LR. Prolactin, immunoregulation, and autoimmune diseases. Semin Arthritis Rheum 1991;20:273–284.
80.
Nagy E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) 1983;102:351–357.
81.
Sun R, Li AL, Wei HM, Tian ZG. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines. Cell Res 2004;14:67–73.
82.
Baines MG, Pross HF, Millar KG. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IV. The suppressive effect of normal pregnancy. Am J Obstet Gynecol 1978;130:741–744.
83.
Goldsobel A, Ank B, Spina C, Giorgi J, Stiehm ER. Phenotypic and cytotoxic characteristics of the immune cells of the human placenta. Cell Immunol 1986;97:335–343.
84.
Bouyou-Akotet MK, Issifou S, Meye JF, Kombila M, Ngou-Milama E, Luty AJ, Kremsner PG, Mavoungou E. Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies. Clin Infect Dis 2004;38:342–347.
85.
Pearson RD. Malaria in pregnancy: the “cortisol” and “prolactin” hypotheses. Clin Infect Dis 2004;39:146–147.
86.
Mavoungou E, Bouyou-Akotet MK, Kremsner PG. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30). Clin Exp Immunol 2005;139:287–296.
87.
Diagne N, Rogier C, Sokhna CS, Tall A, Fontenille D, Roussilhon C, Spiegel A, Trape JF. Increased susceptibility to malaria during the early postpartum period. N Engl J Med 2000;343:598–603.
88.
Bouyou-Akotet MK, Adegnika AA, Agnandji ST, Ngou-Milama E, Kombila M, Kremsner PG, Mavoungou E. Cortisol and susceptibility to malaria during pregnancy. Microbes Infect 2005;7:1217–1223.
89.
Matera L, Cardoso E, Veglia F, Cesano A, Bellone G, Vuolo A, Molinatti GM. Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytes. J Clin Lab Immunol 1988;27:77–81.
90.
Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E, Conte R, Biassoni R, Bottino C, Moretta L, Moretta A. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A 2003;100:4120–4125.

Figures

..................................................

Figure 1: NK cells function through a diverse repertoire of activating and inhibitory receptors. Activating receptor ligation triggers the cytotoxic mechanism, while inhibitory receptors protect from NK cell lysis. Since multiple receptors are involved between NK cells and their targets, the decision of whether or not to kill a target is the net sum of all receptor interactions, and inhibitory receptor signaling is dominant. Both classical and nonclassical class I MHC (left side) and non-MHC ligands (right side) are known for many NK cell receptors.

Figure 1

..................................................

Figure 2: Specificity of NK cell function. In contrast to T cells, which require class I MHC to kill their targets, inhibitory KIRs have exactly the opposite effect.

Figure 2

..................................................

 

Source: Clin Med Res. vol 4(1) pp. 33–41,  March 2006

Table

..................................................
Table 1: Characteristics of NK cell receptors.
Receptor Family Genes Species Function Known ligands
KIR Ig Multigene H, Hd, Ho Activating or inhibitory Broad MHC I specificity
LIR/ILT Ig Multigene H Activating or inhibitory Broad MHC I specificity
NKp30 Ig Single H, Hd, Ro Activating ?
NKp44 Ig Single H Activating Hemagglutinins
NKp46 Ig Single H, Hd, Ro Activating Hemagglutinins
NKp80 Ig Single H Activating ?
Siglec-7 Ig Single H Inhibitory Sialic acid
LAIR Ig Single H Inhibitory Ep-CAM
2B4 Ig Single H, Ro Activating CD48
NKG2D CLD Single H, Hd, Ro Activating MICA/B, ULBP
Ly49 CLD Multigene H, Hd, Ro Activating or inhibitory HLA I, M157, Hm1-C4
CD94/NKG CLD Multigene H, Hd, Ro Activating or inhibitory HLA-E, Qa-1b
KLRB1 CLD Multigene H, Hd, Ro Activating or inhibitory C-type lectin related molecule
TLR Toll like Multigene A, V Activating Pathogen- associated molecules

A, arthropods; CLD, C-type lectin domain family; H, human; Ho, humanoids; HLA, human leukocyte antigen; Ig, immunoglobulin superfamily; ILT, immunoglobulin-like transcript receptors; KIR, killer immunoglobulin-like receptors; LIR, leukocyte immunoglobulin-like receptors; MHC, major histocompatibility complex; NK, natural killer; Ro, rodents; TLR, toll-like receptors; V, vertebrates.

..................................................

 

Source: Clin Med Res. vol 4(1) pp. 33–41,  March 2006

http://www.biology-online.org/articles/interactions_natural_killer_cells/abstract.html